Suppr超能文献

垂体切除大鼠中间歇性和持续性生长激素给药对血清生长调节素-C/胰岛素样生长因子I及肝脏生长激素受体的不同影响

Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats.

作者信息

Maiter D, Underwood L E, Maes M, Davenport M L, Ketelslegers J M

机构信息

Unité de Diabétologie et Nutrition, University of Louvain School of Medicine, Brussels, Belgium.

出版信息

Endocrinology. 1988 Aug;123(2):1053-9. doi: 10.1210/endo-123-2-1053.

Abstract

To determine if the pattern of GH delivery is important for the regulation of serum somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) and liver somatogenic receptors, we have measured serum Sm-C/IGF-I concentrations and free (H2O-treated homogenates) and total (MgCl2-treated homogenates) liver GH-binding sites in hypophysectomized rats treated for 7 days with rat GH (rGH), given either continuously by osmotic minipumps (50 and 250 micrograms/day) or intermittently (four sc injections of 12.5 micrograms/day). At a daily dose of 50 micrograms, intermittent rGH produced greater weight gain [+29.7 +/- 0.8 g (mean +/- SE)] than continuous GH infusion (23.3 +/- 2.0 g; P less than 0.01). Likewise, the serum Sm-C/IGF-I concentration rose more with intermittent (0.33 +/- 0.1 U/ml) than with continuous delivery (0.17 +/- 0.01 U/ml; P less than 0.01). The serum Sm-C/IGF-I level achieved with repeated GH injections was even greater than that after continuous delivery of a 5-fold higher GH dose (250 micrograms/day; 0.27 +/- 0.02 U/ml; P less than 0.05). Continuous infusions of 50 and 250 micrograms rGH/day increased the number of liver total GH receptors by 2.5-fold over that of controls. In contrast, frequent GH injections did not affect GH binding, and the serum Sm-C/IGF-I concentration did not correlate with liver GH-binding sites in the GH-injected rats (r = 0.189; P = NS). Induction of hepatic PRL receptors was 10-fold higher when GH was given continuously than when it was given intermittently. The close correlation observed between GH- and PRL-binding sites in all GH-treated rats (r = 0.955; P less than 0.001) suggests that their regulation may be linked. These data suggest that the regulatory mechanism controlling Sm-C/IGF-I production and growth might be different from those that regulate GH receptor concentrations, with GH pulses being crucial for the maximal stimulation of Sm-C/IGF and growth, but continuous exposure to GH being required for up-regulation of liver GH receptors.

摘要

为了确定生长激素(GH)的给药模式对血清生长调节素C/胰岛素样生长因子I(Sm-C/IGF-I)及肝脏生长激素受体调节是否重要,我们测定了经垂体切除的大鼠在接受大鼠GH(rGH)治疗7天后的血清Sm-C/IGF-I浓度以及肝脏GH结合位点,其中游离结合位点(经水处理的匀浆)和总结合位点(经氯化镁处理的匀浆)分别进行测定。这些大鼠分别通过渗透微型泵持续给予rGH(50和250微克/天)或间断给予(每天皮下注射4次,每次12.5微克)。在每日剂量为50微克时,间断给予rGH比持续输注GH导致更大的体重增加[+29.7±0.8克(均值±标准误)](持续输注为23.3±2.0克;P<0.01)。同样,血清Sm-C/IGF-I浓度在间断给药时升高幅度(0.33±0.1 U/ml)大于持续给药时(0.17±0.01 U/ml;P<0.01)。通过重复注射GH所达到的血清Sm-C/IGF-I水平甚至高于持续给予5倍高剂量GH(250微克/天;0.27±0.02 U/ml)时的水平(P<0.05)。每天持续输注50和250微克rGH使肝脏总GH受体数量比对照组增加2.5倍。相比之下,频繁注射GH不影响GH结合,且在接受GH注射的大鼠中血清Sm-C/IGF-I浓度与肝脏GH结合位点无相关性(r = 0.189;P = 无显著性差异)。当持续给予GH时,肝脏催乳素(PRL)受体的诱导作用比间断给予时高10倍。在所有接受GH治疗的大鼠中观察到GH结合位点与PRL结合位点之间存在密切相关性(r = 0.955;P<0.001),这表明它们的调节可能存在关联。这些数据表明,控制Sm-C/IGF-I产生和生长的调节机制可能与调节GH受体浓度的机制不同,GH脉冲对于Sm-C/IGF和生长的最大刺激至关重要,但持续暴露于GH是肝脏GH受体上调所必需的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验